USPTO serial 99702206
MLI2
Status 641Office Action
- Filing date
- Mar 13, 2026
- Status date
- Jul 16, 2026
- Registration date
- —
- Examiner
- KRUSSMAN, IAN GEORGE
Need help with MLI2?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: 16 Oct 2026
Office Action issues
The USPTO Examiner has determined that your mark, 'MLI2', is currently considered descriptive and potentially generic, which creates significant hurdles for registration. However, we are pleased to note that no conflicting trademarks were found.
Owner
VICTORY O AMUNGA
SAN DIEGO, CA, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service (SAAS) services featuring software for pharmacovigilance, adverse event data analysis, medication safety monitoring, and analysis of FDA Adverse Event Reporting System (FAERS) data | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Jul 16, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 16, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Jul 16, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jul 15, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jul 14, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 13, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Mar 13, 2026 | NWAP | NEW APPLICATION ENTERED |